Abiopharma

GXO Leaders Receive 2026 Women in Supply Chain Awards

Otis to Provide More Than 250 Elevators and Escalators to Tianjin 117 Tower, Chinas New Supertall Landmark

Castle Biosciences Approved for Dual Listing on Nasdaq Texas

Freightos Reports Second Quarter 2026 Results

Dynatrace Announces Proposed Private Placement of $1.25 Billion of Exchangeable Senior Notes

SOLITUDE PIPELINE SYSTEM REACHES FINAL INVESTMENT DECISION TO TRANSPORT GAS FROM THE PERMIAN BASIN TO THE GULF COAST

United Therapeutics Corporation Announces Full Enrollment of the TETON-PPF Study of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis

Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update

Everspin to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026

TAGRISSO® (osimertinib) plus savolitinib demonstrated statistically significant and clinically meaningful improvements in progression-free and overall survival in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO

VinFasts Technology Roadmap: Advancing Smart Mobility Through Innovation

Stakeholder Gold Corp. Begins Trading on OTCQX Best Market

Kratos and GE Aerospace’s GEK800 Engine Receives U.S. Military Type Designation F143-ZZ-100 and EMD Contract Award for JASSM

Barings Global Short Duration High Yield Fund Announces August 2026 Monthly Distribution of $0.1223 per Share

EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD